• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

撒哈拉以南非洲以及中南亚和东南亚国家心理健康投资案例研究的跨国分析。

Cross-country analysis of national mental health investment case studies in sub-Saharan Africa and Central, South and South-East Asia.

作者信息

Chisholm Dan, Lee Yong Yi, Baral Phanindra Prasad, Bhagwat Sadhana, Dombrovskiy Vladislav, Grafton Daniel, Kontsevaya Anna, Huque Rumana, Kalani Okware Kenneth, Kulikov Alexey, Marahatta Kedar, Mavunganidze Patience, Omar Nasri, Prasai Devi, Putoud Nadia, Tsoyi Elena, Vergara Jasmine

机构信息

Department of Mental Health and Substance Use, World Health Organization (WHO), Geneva, Switzerland.

Health Economics Division, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

出版信息

Front Health Serv. 2023 Jul 18;3:1214885. doi: 10.3389/frhs.2023.1214885. eCollection 2023.

DOI:10.3389/frhs.2023.1214885
PMID:37533704
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10392930/
Abstract

INTRODUCTION

Despite the increasing interest in and political commitment to mental health service development in many regions of the world, there remains a very low level of financial commitment and corresponding investment. Assessment of the projected costs and benefits of scaling up the delivery of effective mental health interventions can help to promote, inform and guide greater investment in public mental health.

METHODS

A series of national mental health investment case studies were carried out (in Bangladesh, Kenya, Nepal, Philippines, Uganda, Uzbekistan and Zimbabwe), using standardized guidance developed by WHO and UNDP and implemented by a multi-disciplinary team. Intervention costs and the monetized value of improved health and production were computed in national currency units and, for comparison, US dollars. Benefit-cost ratios were derived.

FINDINGS

Across seven countries, the economic burden of mental health conditions was estimated at between 0.5%-1.0% of Gross Domestic Product. Delivery of an evidence-based package of mental health interventions was estimated to cost US$ 0.40-2.40 per capita per year, depending on the country and its scale-up period. For most conditions and country contexts there was a return of >1 for each dollar or unit of local currency invested (range: 0.0-10.6 to 1) when productivity gains alone are included, and >2 (range: 0.4-30.3 to 1) when the intrinsic economic value of health is also considered. There was considerable variation in benefit-cost ratios between intervention areas, with population-based preventive measures and treatment of common mental, neurological and conditions showing the most attractive returns when all assessed benefits are taken into account.

DISCUSSION AND CONCLUSION

Performing a mental health investment case can provide national-level decision makers with new and contextualized information on the outlays and returns that can be expected from renewed local efforts to enhance access to quality mental health services. Economic evidence from seven low- and middle-income countries indicates that the economic burden of mental health conditions is high, the investment costs are low and the potential returns are substantial.

摘要

引言

尽管世界许多地区对精神卫生服务发展的兴趣日益浓厚,且政治上也做出了承诺,但财政投入和相应投资水平仍然很低。评估扩大提供有效精神卫生干预措施的预计成本和效益有助于促进、告知并指导对公共精神卫生的更多投资。

方法

利用世界卫生组织和联合国开发计划署制定并由一个多学科团队实施的标准化指南,开展了一系列国家精神卫生投资案例研究(在孟加拉国、肯尼亚、尼泊尔、菲律宾、乌干达、乌兹别克斯坦和津巴布韦)。干预成本以及改善健康和生产的货币化价值以本国货币单位计算,并为便于比较,换算为美元。得出了效益成本比。

研究结果

在七个国家中,精神卫生状况的经济负担估计占国内生产总值的0.5%-1.0%。提供一套循证精神卫生干预措施估计每年人均成本为0.40-2.40美元,具体取决于国家及其扩大规模的时期。对于大多数情况和国家背景,仅计入生产力提高时,每投资1美元或当地货币单位的回报大于1(范围:0.0-10.6至1),同时考虑健康的内在经济价值时,回报大于2(范围:0.4-30.3至1)。各干预领域的效益成本比差异很大,当考虑所有评估效益时,基于人群的预防措施以及常见精神、神经疾病的治疗显示出最可观的回报。

讨论与结论

开展精神卫生投资案例研究可为国家层面的决策者提供新的、基于具体情况的信息,说明当地为增加获得优质精神卫生服务的机会而做出新努力时可能产生的支出和回报。来自七个低收入和中等收入国家的经济证据表明,精神卫生状况的经济负担很高,投资成本很低,潜在回报很大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ab3/10392930/8eed3281b1fa/frhs-03-1214885-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ab3/10392930/724e38e4a04b/frhs-03-1214885-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ab3/10392930/a52e524693ff/frhs-03-1214885-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ab3/10392930/e578a4e1b696/frhs-03-1214885-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ab3/10392930/8eed3281b1fa/frhs-03-1214885-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ab3/10392930/724e38e4a04b/frhs-03-1214885-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ab3/10392930/a52e524693ff/frhs-03-1214885-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ab3/10392930/e578a4e1b696/frhs-03-1214885-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ab3/10392930/8eed3281b1fa/frhs-03-1214885-g004.jpg

相似文献

1
Cross-country analysis of national mental health investment case studies in sub-Saharan Africa and Central, South and South-East Asia.撒哈拉以南非洲以及中南亚和东南亚国家心理健康投资案例研究的跨国分析。
Front Health Serv. 2023 Jul 18;3:1214885. doi: 10.3389/frhs.2023.1214885. eCollection 2023.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Scaling-up services for psychosis, depression and epilepsy in sub-Saharan Africa and South Asia: development and application of a mental health systems planning tool (OneHealth).在撒哈拉以南非洲和南亚地区扩大精神分裂症、抑郁症和癫痫的服务规模:精神卫生系统规划工具(OneHealth)的制定和应用。
Epidemiol Psychiatr Sci. 2017 Jun;26(3):234-244. doi: 10.1017/S2045796016000408. Epub 2016 Sep 19.
4
Tuberculosis结核病
5
Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income countries.投资于五个主要传染病的后期临床试验和候选产品的生产:对三个中等收入国家投资的效益和成本的建模研究。
Lancet Glob Health. 2022 Jul;10(7):e1045-e1052. doi: 10.1016/S2214-109X(22)00206-6.
6
Cost-Effectiveness and Affordability of Interventions, Policies, and Platforms for the Prevention and Treatment of Mental, Neurological, and Substance Use Disorders预防和治疗精神、神经及物质使用障碍的干预措施、政策和平台的成本效益及可负担性
7
Scaling-up treatment of depression and anxiety: a global return on investment analysis.扩大抑郁症和焦虑症治疗规模:一项全球投资回报率分析。
Lancet Psychiatry. 2016 May;3(5):415-24. doi: 10.1016/S2215-0366(16)30024-4. Epub 2016 Apr 12.
8
The 2023 Latin America report of the Countdown on health and climate change: the imperative for health-centred climate-resilient development.《2023年健康与气候变化倒计时拉丁美洲报告:以健康为中心的气候适应型发展的必要性》
Lancet Reg Health Am. 2024 Apr 23;33:100746. doi: 10.1016/j.lana.2024.100746. eCollection 2024 May.
9
The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.吸烟及降低吸烟率的经济影响:证据综述
Tob Use Insights. 2015 Jul 14;8:1-35. doi: 10.4137/TUI.S15628. eCollection 2015.
10
Assessing the cost-effectiveness of contraceptive methods from a health provider perspective: case study of Kiambu County Hospital, Kenya.从卫生服务提供者角度评估避孕方法的成本效益:肯尼亚基安布县医院案例研究。
Reprod Health. 2022 Jan 17;19(1):11. doi: 10.1186/s12978-021-01308-3.

引用本文的文献

1
Analysis of Indirect Costs of Absence Associated with Mental Disorders on the Basis of Social Security Data (2012-2023).基于社会保障数据(2012 - 2023年)对与精神障碍相关的缺勤间接成本的分析
Healthcare (Basel). 2024 Sep 6;12(17):1784. doi: 10.3390/healthcare12171784.

本文引用的文献

1
School-based socio-emotional learning programs to prevent depression, anxiety and suicide among adolescents: a global cost-effectiveness analysis.基于学校的社会情感学习计划预防青少年抑郁、焦虑和自杀:全球成本效益分析。
Epidemiol Psychiatr Sci. 2023 Jul 12;32:e46. doi: 10.1017/S204579602300029X.
2
The global return on investment from preventing and treating adolescent mental disorders and suicide: a modelling study.预防和治疗青少年精神障碍和自杀的全球投资回报率:一项建模研究。
BMJ Glob Health. 2022 Jun;7(6). doi: 10.1136/bmjgh-2021-007759.
3
Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic.
2020 年 COVID-19 大流行期间 204 个国家和地区的抑郁和焦虑障碍的全球患病率和负担。
Lancet. 2021 Nov 6;398(10312):1700-1712. doi: 10.1016/S0140-6736(21)02143-7. Epub 2021 Oct 8.
4
The cost-effectiveness of banning highly hazardous pesticides to prevent suicides due to pesticide self-ingestion across 14 countries: an economic modelling study.在14个国家禁止高危害农药以预防因自服农药导致自杀的成本效益:一项经济建模研究
Lancet Glob Health. 2021 Mar;9(3):e291-e300. doi: 10.1016/S2214-109X(20)30493-9. Epub 2020 Dec 17.
5
Economics and mental health: the current scenario.经济学与心理健康:当前状况
World Psychiatry. 2020 Feb;19(1):3-14. doi: 10.1002/wps.20692.
6
Scaling-up treatment of depression and anxiety: a global return on investment analysis.扩大抑郁症和焦虑症治疗规模:一项全球投资回报率分析。
Lancet Psychiatry. 2016 May;3(5):415-24. doi: 10.1016/S2215-0366(16)30024-4. Epub 2016 Apr 12.
7
Global health 2035: a world converging within a generation.《2035年全球健康:一代人时间内的世界融合》
Lancet. 2013 Dec 7;382(9908):1898-955. doi: 10.1016/S0140-6736(13)62105-4. Epub 2013 Dec 3.
8
Cost effectiveness of strategies to combat neuropsychiatric conditions in sub-Saharan Africa and South East Asia: mathematical modelling study.撒哈拉以南非洲和东南亚神经精神疾病防治策略的成本效益:数学模型研究。
BMJ. 2012 Mar 2;344:e609. doi: 10.1136/bmj.e609.
9
Days out of role due to common physical and mental conditions: results from the WHO World Mental Health surveys.因常见身心状况缺勤的天数:来自世卫组织世界心理健康调查的结果。
Mol Psychiatry. 2011 Dec;16(12):1234-46. doi: 10.1038/mp.2010.101. Epub 2010 Oct 12.